This sort of announcement does nothing for the company’s credibility imo.
’warmth’ isn’t even their study - and they’ve put it in a price sensitive document, and headline claim it supports Veyonda; unbelievable!!
this sort of comparison of survivals between totally different studies is completely invalid. 71% increased survival ? Seriously?
really poor stuff imo
Ann: New Independent Trial Data Supports Potential of Veyonda, page-6
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.5¢ | $6.819K | 59.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 659373 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 9423 | 2 |
View Market Depth
| Last trade - 11.28am 04/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |